NRT Smoking Cessation Aids in Estonia
Sales of NRT smoking cessation aids are strongly linked to consumers’ economic wellbeing. Industry sources indicate that smoking prevalence usually increases during more difficult economy period, but declines when the economy grows and purchasing power improves. Therefore, current value sales witnessed strong growth in 2012, driven by improving living standards. Importantly, growing health awareness significantly boosted demand for NRT smoking cessation aids in 2012.
Euromonitor International's NRT Smoking Cessation Aids in Estonia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2008-2012, allowing you to identify the sectors driving growth. Forecasts to 2017 illustrate how the market is set to change.
Product coverage: NRT Gum, NRT Inhalators, NRT Lozenges, NRT Patches, Other NRT.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
Euromonitor International's NRT Smoking Cessation Aids in Estonia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2008-2012, allowing you to identify the sectors driving growth. Forecasts to 2017 illustrate how the market is set to change.
Product coverage: NRT Gum, NRT Inhalators, NRT Lozenges, NRT Patches, Other NRT.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the NRT Smoking Cessation Aids market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Indicators
Table 1 Number of Smokers by Gender 2007-2012
Category Data
Table 2 Sales of NRT Smoking Cessation Aids by Category: Value 2007-2012
Table 3 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2007-2012
Table 4 NRT Gum Flavours: % Value Breakdown 2007-2012
Table 5 NRT Smoking Cessation Aids Company Shares 2008-2012
Table 6 NRT Smoking Cessation Aids Brand Shares 2009-2012
Table 7 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2012-2017
Table 8 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2012-2017
Executive Summary
Consumer Health Sales Continue To Recover in 2012
Consumers Focus More on Trusted Brands
Competition Remains Tough Due To the Spread of Private Label
Chemists/pharmacies Dominates Consumer Health in Estonia
the Economy Impacts Consumer Patterns
Key Trends and Developments
Economic Growth Shifts From Exports To Internal Consumption in 2012
Debate on Low Competition in Chemists/pharmacies
the Ageing Population Trend Positively Impacts Consumer Health
Market Indicators
Table 9 Consumer Expenditure on Health Goods and Medical Services 2007-2012
Table 10 Life Expectancy at Birth 2007-2012
Market Data
Table 11 Sales of Consumer Health by Category: Value 2007-2012
Table 12 Sales of Consumer Health by Category: % Value Growth 2007-2012
Table 13 Consumer Health Company Shares 2008-2012
Table 14 Consumer Health Brand Shares 2009-2012
Table 15 Sales of Consumer Health by Distribution Format: % Analysis 2007-2012
Table 16 Sales of Consumer Health by Category and Distribution Format: % Analysis 2012
Table 17 Forecast Sales of Consumer Health by Category: Value 2012-2017
Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2012-2017
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicines
Switches
Summary 1 OTC Healthcare Switches 2010-2012
Sources
Summary 2 Research Sources
Trends
Switches
Competitive Landscape
Prospects
Category Indicators
Table 1 Number of Smokers by Gender 2007-2012
Category Data
Table 2 Sales of NRT Smoking Cessation Aids by Category: Value 2007-2012
Table 3 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2007-2012
Table 4 NRT Gum Flavours: % Value Breakdown 2007-2012
Table 5 NRT Smoking Cessation Aids Company Shares 2008-2012
Table 6 NRT Smoking Cessation Aids Brand Shares 2009-2012
Table 7 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2012-2017
Table 8 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2012-2017
Executive Summary
Consumer Health Sales Continue To Recover in 2012
Consumers Focus More on Trusted Brands
Competition Remains Tough Due To the Spread of Private Label
Chemists/pharmacies Dominates Consumer Health in Estonia
the Economy Impacts Consumer Patterns
Key Trends and Developments
Economic Growth Shifts From Exports To Internal Consumption in 2012
Debate on Low Competition in Chemists/pharmacies
the Ageing Population Trend Positively Impacts Consumer Health
Market Indicators
Table 9 Consumer Expenditure on Health Goods and Medical Services 2007-2012
Table 10 Life Expectancy at Birth 2007-2012
Market Data
Table 11 Sales of Consumer Health by Category: Value 2007-2012
Table 12 Sales of Consumer Health by Category: % Value Growth 2007-2012
Table 13 Consumer Health Company Shares 2008-2012
Table 14 Consumer Health Brand Shares 2009-2012
Table 15 Sales of Consumer Health by Distribution Format: % Analysis 2007-2012
Table 16 Sales of Consumer Health by Category and Distribution Format: % Analysis 2012
Table 17 Forecast Sales of Consumer Health by Category: Value 2012-2017
Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2012-2017
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicines
Switches
Summary 1 OTC Healthcare Switches 2010-2012
Sources
Summary 2 Research Sources